Zepp Health (NYSE:ZEPP) Given a $13.87 Price Target at Fundamental Research

Fundamental Research set a $13.87 target price on Zepp Health (NYSE:ZEPP) in a research note published on Tuesday morning,BayStreet.CA reports. The firm currently has a buy rating on the stock.

Zepp Health Price Performance

Shares of ZEPP opened at $2.54 on Tuesday. The firm’s 50 day moving average price is $2.88 and its 200 day moving average price is $3.02. The company has a market cap of $38.16 million, a P/E ratio of -1.01 and a beta of 0.71. The company has a quick ratio of 0.87, a current ratio of 1.21 and a debt-to-equity ratio of 0.13. Zepp Health has a fifty-two week low of $2.06 and a fifty-two week high of $4.38.

Hedge Funds Weigh In On Zepp Health

A hedge fund recently bought a new stake in Zepp Health stock. Virtu Financial LLC bought a new position in shares of Zepp Health Co. (NYSE:ZEPP) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 13,056 shares of the company’s stock, valued at approximately $57,000. Virtu Financial LLC owned approximately 0.09% of Zepp Health as of its most recent filing with the SEC. Institutional investors own 52.61% of the company’s stock.

About Zepp Health

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.